Sonnet BioTherapeutics Holdings, Inc.
SONNDelisted Dec 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106838
Sonnet BioTherapeutics Holdings, Inc. was delisted on Dec 2, 2025; its insiders filed their last Form 4 on Dec 4, 2025; 27 institutions reported holding it in 13F filings for Q3 2025, worth $3.53M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Sonnet BioTherapeutics Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Sonnet BioTherapeutics Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kenney Richard T | Chief Medical Officer | 0 | Dec 4, 2025 | 1 |
| McAndrew Stephen J | Chief Business Officer | 0 | Dec 3, 2025 | 1 |
| Griffith Donald J. | Chief Financial Officer | 0 | Dec 3, 2025 | 1 |
| Dyrness Albert D. | Director | 0 | Dec 3, 2025 | 1 |
| Bhatt Nailesh | Director | 0 | Dec 3, 2025 | 1 |
| Cini John K. | Director | 0 | Dec 3, 2025 | 1 |
| Rao Raghu | Chief Executive Officer | 0 | Dec 3, 2025 | 1 |
| Dexter Susan | Director | 0 | Dec 3, 2025 | 1 |
| McNeill Lori | Director | 0 | Dec 3, 2025 | 1 |
| Mohan Pankaj | Chairman, President and CEO | 14,987 | Dec 5, 2024 | 0 |
| Cross John Harry III | Chief Financial Officer | 1,588 | Dec 5, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2023 (view filing) | Oct 27 | Same day | Rao RaghuDirector | PPurchase | +15.6K | – | – | +1,315.2%16.8K after | |
| Oct 27, 2023 (view filing) | Oct 27 | Same day | Rao RaghuDirector | PPurchase | +31.3K | – | – | –31.3K after | Derivative |
| Oct 27, 2023 (view filing) | Oct 27 | Same day | Mohan PankajChairman, President and CEO | PPurchase | +34.4K | – | – | +136.7%59.5K after | |
| Oct 27, 2023 (view filing) | Oct 27 | Same day | Mohan PankajChairman, President and CEO | PPurchase | +68.8K | – | – | –68.8K after | Derivative |
| Jun 15, 2023 (view filing) | Jun 14 | 1 day | Dexter SusanChief Technical Officer | PPurchase | +10.0K | $0.70 | +$7.00K | +42.3%33.7K after | |
| May 31, 2023 (view filing)8:30 AM ET | May 30 | 1 day | Dyrness Albert D.Director | PPurchase | +23.3K | $0.468 | +$10.9K | +407.5%29.0K after | |
| May 18, 2023 (view filing)8:00 AM ET | May 17 | 1 day | Bhatt NaileshDirector | PPurchase | +25.0K | $0.232 | +$5.80K | +436.1%30.7K after | |
| May 15, 2023 (view filing)5:17 PM ET | May 15 | Same day | Mohan PankajChairman, President and CEO | PPurchase | +371.6K | $0.223 | +$82.9K | +204.5%553.3K after | |
| Mar 16, 2023 (view filing) | Mar 15 | 1 day | Mohan PankajChairman, President and CEO | PPurchase | +60.0K | $0.59 | +$35.4K | +49.3%181.7K after |